Navigation Links
BCC Research Publishes a New Report on Global Markets for Next Generation Sequencing (NGS)
Date:8/14/2013

Wellesley, MA (PRWEB) August 14, 2013

According to a new technical market research report, Next Generation Sequencing: Emerging Clinical Applications and Global Markets (Report code: BIO126A) from BCC Research (http://www.bccresearch.com), the global market for next generation sequencing is expected to reach $510.7 million in 2013. BCC Research forecasts the market to reach $7.6 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 71.6% for the period 2013 to 2018.

The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP led to significant improvements in the efficiency and costs of DNA sequencing. In 2005, the launch of next generation sequencing (NGS) technologies changed the structure of the industry radically and opened up exciting new market applications. As a result, the costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests.

The NGS clinical market is still relatively young and emerging, yet it holds great commercial promise. BCC Research expects the decline in sequencing costs and NGS informatics (i.e., the handling and interpretation of massive amounts of genetic data) to emerge as a key focus area for clinical applications in the future.

NGS pre- and post-natal diagnostics comprise an important current market segment. The pre- and post-natal disease class, as a segment, is expected to reach $393.3 million in 2013. BCC Research projects this market to grow to nearly $2.1 billion in 2018, and register a CAGR of 39.4%. NGS-based diagnostics for cancer also present a significant high-growth market opportunity. The cancer disease class, as a segment, is expected to reach $63.7 million in 2013. This segment is projected to reach nearly $2.5 billion in 2018, and register a CAGR of 108.3%.

According to BCC Research, the global market for NGS is being driven by the clinical value of many applications and the commercial success of several tests. The commercial potential of NGS is further enhanced with payors and insurance companies offering coverage for these tests.

NGS is a game-changing technology that is maturing at the right time for it to make a major impact on molecular diagnostics. This new report examines the technology and studies its clinical markets in detail to provide a context for strategic decision making. The report provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status, and companies.

This report will be useful to companies involved in the clinical, genetic testing and sequencing industries. It will be particularly valuable for companies in industries such as life science research tools, NGS instruments, molecular diagnostics, informatics clinical laboratories, pharmaceutical, biotechnology, microfluidics, lab-on-a-chip, and sample preparation.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11018128.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, with its ... place for a head lice treatment salon to set up ... Tuscan restaurant and a French bistro on E Madison Ave, ... aren,t just any old lice clinic, we pride ourselves on ... and release some of the stigma associated with lice. Everyone ...
(Date:2/23/2017)... INDIANAPOLIS, Ind. (PRWEB) , ... February 23, 2017 ... ... Commercialization Award during the 12th annual Inventors Recognition Reception at Purdue Research ... annually to a faculty member in recognition of outstanding contributions to, and success ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , a ... Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out from ... and clinical applications. The terms of the transaction were not disclosed. , ...
Breaking Biology Technology:
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/26/2017)... 2017  Acuity Market Intelligence today released the ... Identity".  Acuity characterizes 2017 as a "breakout" year ... reflects a new understanding of the potential benefits ... digital identity are often perceived as threats to ... Principal of Acuity Market intelligence. "However, taken together ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):